BioCardia Reports Third Quarter 2026 Business Highlights and Financial ResultsGlobeNewsWire • Thursday
BioCardia to Host Q3 2026 Financial Results and Corporate Update Conference Call on November 12, 2026GlobeNewsWire • Monday
BioCardia Completes Clinical Consultation Process with Japan's PMDA for CardiAMP Cell Therapy System, Advancing Toward Submission of Marketing Approval ApplicationGlobeNewsWire • 11/06/26
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this QuarterGlobeNewsWire • 10/19/26
BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific MeetingGlobeNewsWire • 10/07/26
BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ CatheterGlobeNewsWire • 10/01/26
BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin SubmissionGlobeNewsWire • 09/23/26
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire • 09/10/26
BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for ApprovalGlobeNewsWire • 08/24/26
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026GlobeNewsWire • 08/05/26
BioCardia Letter to Stockholders on 2026 Priorities and Strategic OpportunitiesGlobeNewsWire • 06/18/26
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEFGlobeNewsWire • 06/05/26
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina FrequencyGlobeNewsWire • 05/21/26
BioCardia Reports First Quarter 2026 Business Highlights and Financial ResultsGlobeNewsWire • 05/15/26
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026GlobeNewsWire • 05/11/26
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart FailureGlobeNewsWire • 04/20/26